These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 30006785)

  • 1. Ghrelin and acyl ghrelin levels are associated with inflammatory and nutritional markers and with cardiac and vascular dysfunction parameters in hemodialysis patients.
    Rusu CC; Racasan S; Moldovan D; Potra A; Tirinescu D; Budurea C; Orasan R; Patiu IM; Bondor C; Vladutiu D; Delean D; Danu A; Kacso IM
    Int Urol Nephrol; 2018 Oct; 50(10):1897-1906. PubMed ID: 30006785
    [TBL] [Abstract][Full Text] [Related]  

  • 2. N-Terminal Pro-Brain Natriuretic Peptide Correlates with Ghrelin and Acyl-Ghrelin in Pre-Dialysis Chronic Kidney Disease.
    Rusu CC; Anton F; Valea A; Bondor CI
    Int J Mol Sci; 2024 May; 25(11):. PubMed ID: 38891884
    [TBL] [Abstract][Full Text] [Related]  

  • 3. N-Terminal Pro-B-Type Natriuretic Peptide as a Biomarker for Loss of Muscle Mass in Prevalent Hemodialysis Patients.
    Ikeda M; Honda H; Takahashi K; Shishido K; Shibata T
    PLoS One; 2016; 11(11):e0166804. PubMed ID: 27870908
    [TBL] [Abstract][Full Text] [Related]  

  • 4. N-terminal pro brain natriuretic peptide predicts mortality in patients with end-stage renal disease in hemodialysis.
    Madsen LH; Ladefoged S; Corell P; Schou M; Hildebrandt PR; Atar D
    Kidney Int; 2007 Mar; 71(6):548-54. PubMed ID: 17299526
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical significance of N-terminal Pro-B-type natriuretic peptide (NT-proBNP) in hemodialysis patients.
    Helal I; Belhadj R; Mohseni A; Bazdeh L; Drissa H; Elyounsi F; Abdallah TB; Abdelmoula J; Kheder A
    Saudi J Kidney Dis Transpl; 2010 Mar; 21(2):262-8. PubMed ID: 20228511
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The relationship between serum level of N-terminal pro-B-type natriuretic peptide and nutritional status, and inflammation in chronic hemodialysis patients.
    Bednarek-Skublewska A; Zaluska W; Ksiazek A
    Clin Nephrol; 2010 Jan; 73(1):14-20. PubMed ID: 20040347
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Determinants of N-terminal pro-brain natriuretic peptide variation in hemodialysis patients and prediction of survival.
    Snaedal S; Qureshi AR; Carrero JJ; Heimbürger O; Stenvinkel P; Bárány P
    Blood Purif; 2014; 37(2):138-45. PubMed ID: 24732340
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma myeloperoxidase, NT-proBNP, and troponin-I in patients on CAPD compared with those on regular hemodialysis.
    Al-Hweish A; Sultan SS; Mogazi K; Elsammak MY
    Hemodial Int; 2010 Jul; 14(3):308-15. PubMed ID: 20597992
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interaction of malnutrition, N-terminal pro-B-type natriuretic peptide and ventricular remodeling in patients on maintenance hemodialysis.
    Lee YJ; Song BG; Kim MS; Cho S; Chun WJ; Oh JH; Kim SR
    Clin Nephrol; 2013 Apr; 79(4):253-60. PubMed ID: 23149248
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interaction between acyl-ghrelin and BMI predicts clinical outcomes in hemodialysis patients.
    Beberashvili I; Sinuani I; Azar A; Shapiro G; Feldman L; Doenyas-Barak K; Stav K; Efrati S
    BMC Nephrol; 2017 Jan; 18(1):29. PubMed ID: 28100170
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prohormone brain natriuretic peptide (proBNP), BNP and N-terminal-proBNP circulating levels in chronic hemodialysis patients. Correlation with ventricular function, fluid removal and effect of hemodiafiltration.
    Bargnoux AS; Klouche K; Fareh J; Barazer I; Villard-Saussine S; Dupuy AM; Leray-Moragues H; Giuliani I; Canaud B; Cristol JP
    Clin Chem Lab Med; 2008; 46(7):1019-24. PubMed ID: 18624622
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is there association between acyl-ghrelin and inflammation in hemodialysis patients?
    Barros Ade F; Moraes C; Pinto MB; Lobo JC; Mafra D
    J Bras Nefrol; 2013; 35(2):120-6. PubMed ID: 23812569
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum Obestatin: A Biomarker of Cardiovascular and All-Cause Mortality in Hemodialysis Patients.
    Beberashvili I; Katkov A; Sinuani I; Azar A; Shapiro G; Feldman L; Gorelik O; Stav K; Efrati S
    Am J Nephrol; 2018; 47(4):254-265. PubMed ID: 29694945
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The impact of dialysis type on biomarkers for cardiovascular diseases.
    Sahinarslan A; Güz G; Mutluay R; Okyay K; Demirtaş C; Paşaoğlu H; Yalçın R
    Turk Kardiyol Dern Ars; 2011 Sep; 39(6):456-62. PubMed ID: 21918314
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiothoracic Ratio as a Predictor of Cardiovascular Events in a Cohort of Hemodialysis Patients.
    Okute Y; Shoji T; Hayashi T; Kuwamura Y; Sonoda M; Mori K; Shioi A; Tsujimoto Y; Tabata T; Emoto M; Inaba M
    J Atheroscler Thromb; 2017 Apr; 24(4):412-421. PubMed ID: 27629255
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Brain natriuretic peptide and N-terminal proBNP in chronic haemodialysis patients.
    Racek J; Králová H; Trefil L; Rajdl D; Eiselt J
    Nephron Clin Pract; 2006; 103(4):c162-72. PubMed ID: 16645318
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acyl-ghrelin and obestatin plasma levels in different stages of chronic kidney disease.
    Borges N; Moraes C; Barros AF; Carraro-Eduardo JC; Fouque D; Mafra D
    J Ren Nutr; 2014 Mar; 24(2):100-4. PubMed ID: 24462497
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early markers of cardiovascular risk in chronic kidney disease.
    Lai S; Dimko M; Galani A; Coppola B; Innico G; Frassetti N; Mazzei ED; Mariotti A
    Ren Fail; 2015 Mar; 37(2):254-61. PubMed ID: 25394527
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Determining factors of cardiac biomarkers in hemodialysed diabetic and non-diabetic patients].
    Mácsai E; Széll J; Ladányi E; Treszl A; Vásárhelyi B; Madácsy L
    Orv Hetil; 2007 Mar; 148(11):483-8. PubMed ID: 17350919
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NT-proBNP, fluid volume overload and dialysis modality are independent predictors of mortality in ESRD patients.
    Paniagua R; Ventura MD; Avila-Díaz M; Hinojosa-Heredia H; Méndez-Durán A; Cueto-Manzano A; Cisneros A; Ramos A; Madonia-Juseino C; Belio-Caro F; García-Contreras F; Trinidad-Ramos P; Vázquez R; Ilabaca B; Alcántara G; Amato D
    Nephrol Dial Transplant; 2010 Feb; 25(2):551-7. PubMed ID: 19679559
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.